创新药高质量发展政策发布，如何抓住机会？

Market Review - The equity market indices rebounded collectively last week, with the CSI 300 index showing the largest increase of 1.54% [4][5] - The bond market saw a decline in both short and long-term interest rates, with the 10-year government bond yield decreasing by 0.29 basis points to 1.643% [9][12] - The fund market experienced gains in equity funds and secondary bond indices, with the equity fund index rising by 1.25% [14] Equity Product Allocation Strategy - Event-driven strategy includes focusing on funds related to the newly released policy supporting high-quality development of innovative drugs, such as ICBC Medical Health A (006002) and Penghua Medical Technology A (001230) [16] - The asset allocation strategy suggests a balanced core plus a barbell strategy, emphasizing dividend and technology sectors, with recommended funds including Anxin Dividend Select (018381) and Jiashi Hong Kong Internet Core Assets (011924) [18][20] Stable Product Allocation Strategy - Market analysis indicates a net withdrawal of 13,753 billion yuan in central bank operations, maintaining a loose monetary balance [21] - The June PMI data suggests the economy is in a recovery phase, with the manufacturing PMI at 49.7% and the non-manufacturing PMI at 50.5% [21] - Convertible bonds are highlighted as having allocation value, with a median price around 1200, but caution is advised due to potential volatility risks [23][26]